Cargando…
Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients
BACKGROUND: Work disability remains a significant problem in ankylosing spondylitis (AS) and rheumatoid arthritis (RA), despite biological therapy. This study aimed to test the hypothesis that the prevalent symptom of fatigue longitudinally predicts work disability among RA and AS patients commencin...
Autores principales: | Druce, Katie L., Aikman, Laraine, Dilleen, Maria, Burden, Annie, Szczypa, Piotr, Basu, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972438/ https://www.ncbi.nlm.nih.gov/pubmed/29843776 http://dx.doi.org/10.1186/s13075-018-1598-8 |
Ejemplares similares
-
Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008) -
Treatment of ankylosing spondylitis: focus on etanercept
por: Frech, Tracy
Publicado: (2007) -
Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
por: Raffeiner, Bernd, et al.
Publicado: (2014) -
Relapsing Polychondritis in a Patient with Ankylosing Spondylitis Using Etanercept
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2014) -
Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
por: Senabre-Gallego, José Miguel, et al.
Publicado: (2013)